The Institute for Protein Design at the University of Washington School of Medicine describes the plans for its Audacious project, announced April 16, 2019
Advanced technologies can characterize structural variants in human genomes more thoroughly and may improve the power for discovery in clinical genetic research.
A study published in Pediatrics shows more than 60 percent of the 1,025 parents surveyed would support age restrictions for tackling in youth football.
The nanoparticle platform for this respiratory syncytial virus study will be applied to vaccine research on flu, HIV, and more. Seattle startup Icosavax will advance related clinical trials.
